You are here

  • Home
  • Archive
  • Volume 8, Issue 3
  • Cancer cachexia: rationale for the MENAC (Multimodal—Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial

Article metrics

Article menu
Download PDFPDF
Review
Cancer cachexia: rationale for the MENAC (Multimodal—Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial

 

Online download statistics by month:

Online download statistics by month: February 2018 to March 2024

AbstractFullPdf
Feb 20187742420
Mar 20187375644
Apr 20185212831
May 20186212157
Jun 20183022320
Jul 2018277914
Aug 20185024434
Sep 20184152520
Oct 20185843217
Nov 20184861018
Dec 20183261511
Jan 20193411913
Feb 20193101714
Mar 2019389205
Apr 20194471913
May 20194241315
Jun 201943533290
Jul 201952369
Aug 2019318169
Sep 2019274614
Oct 2019521116
Nov 20194371516
Dec 201938096
Jan 2020446179
Feb 2020510147
Mar 2020491128
Apr 2020465912
May 2020497138
Jun 2020256510
Jul 202023263
Aug 202024165
Sep 2020301106
Oct 20204642110
Nov 2020493717
Dec 2020333137
Jan 20213881512
Feb 202133184
Mar 20215641819
Apr 20215321915
May 202118455
Jun 202162176
Jul 20212735
Aug 20213254
Sep 20213851
Oct 202135095
Nov 20213562210
Dec 2021442175
Jan 2022428203
Feb 202238964
Mar 2022563113
Apr 202240299
May 2022484129
Jun 20223792310
Jul 2022261158
Aug 2022576266
Sep 2022408267
Oct 20225613914
Nov 2022371112
Dec 202229995
Jan 202345886
Feb 2023355184
Mar 2023408163
Apr 2023512104
May 202329269
Jun 202341664
Jul 202322860
Aug 202328665
Sep 202322631
Oct 2023433177
Nov 202365652
Dec 2023473117
Jan 2024297157
Feb 202442461
Mar 2024363172
Total2932711041031